Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-754-7 | CAS number: 592-42-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start date: 02 February 2018. Experimental completion date: 01 March 2018.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- Adopted July 21, 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 31 May 2008
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Hexa-1,5-diene
- EC Number:
- 209-754-7
- EC Name:
- Hexa-1,5-diene
- Cas Number:
- 592-42-7
- Molecular formula:
- C6H10
- IUPAC Name:
- hexa-1,5-diene
Constituent 1
- Specific details on test material used for the study:
- 1,5-hexadiene. 9.4% purity.
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: BSC-433-4-0488-5
- Expiration date of the lot/batch:01 June 2018
- Purity test date: 26 June 2017
Analyses conducted to support the information cited in the certificate of analysis for the test item were not conducted in compliance with the GLP or GMP regulations. The characterization of the test item was conducted under a sponsor or sponsor subcontractor quality system. Concentration, stability and homogeneity of test item formulations were not determined in this study. However, to limit the impact, the test item preparation was performed with approved procedures and documented in detail. Preparations were visually inspected for homogeneity prior to use and all preparations were used within 4 hours after preparation of the formulation.
Method
- Target gene:
- Histidine locus in several strains of Salmonella typhimurium and tryptophan locus of Escherichia coli.
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: Additional mutations: rfa (deep rough, defective lipolysaccharide cellcoat), gal (galactose metabolism), chl (nitrate reductase), bio (biotin synthesis), uvrB (loss of excision repair system)
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 homogenate (rat liver microsomal enzymes) prepared from male Sprague Dawley rats injected intraperitoneally with Aroclor 1254
- Test concentrations with justification for top dose:
- Direct plate assay (first experiment): 1,5-hexadiene was initially tested in the tester strains TA100 and WP2uvrA as a dose-range finding test with concentrations of 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 ¿g/plate in the absence and presence of S9-mix. Based on the results of the dose-range finding test, the following dose-range was selected for the mutation assay with the tester strains, TA1535, TA1537 and TA98 in the absence and presence of S9-mix: 17, 52, 164, 512, 1600 and 5000 ¿g/plate.
Pre-incubation assay (second experiment): Based on the results of the first mutation assay, 1,5-hexadiene was tested up to the dose level of 5000 ¿g/plate in the tester strains TA1535, TA1537, TA98, TA100 and WP2uvrA.
Pre-incubation assay (third experiment): Due to the cytotoxicity in the second experiment, only three analyzable dose levels were left for the determination of the mutagenicity of the test item in the tester strain TA1535 in the presence of S9-mix and in tester strain TA1537 in the absence and presence of S9-mix. Therefore a third experiment was performed with concentrations of 1.7, 5.4 and 17 ¿g/plate to provide additional information. - Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: ICR-191, without metabolic activation. 1-aminoanthracene, with metabolic activation.
- Remarks:
- Solvents for positive controls: DMSO; saline for sodium azide.
- Details on test system and experimental conditions:
- Dose-range finding test. Selection of an adequate range of doses was based on a dose-range finding test with the strains TA100 and WP2uvrA, both with and without S9-mix. Eight concentrations, 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 ¿g/plate were tested in triplicate. The highest concentration of 1,5-hexadiene used in the subsequent mutation assays was 5000 ¿g/plate or the level at which the test item inhibited bacterial growth. At least five different doses (increasing with approximately half-log steps) of the test item were tested in triplicate in each strain in the absence and presence of S9-mix. The first experiment was a direct plate assay and the second experiment was a pre-incubation assay. The negative control (vehicle) and relevant positive controls were concurrently tested in each strain in the presence and absence of S9-mix.
First experiment: direct plate assay. The dose-range finding study with two tester strains is reported as a part of the direct plate assay. In the second part of this experiment, the test item was tested both in the absence and presence of S9-mix in the tester strains TA1535, TA1537 and TA98. Top agar in top agar tubes was melted by heating to 45 ± 2°C. The following solutions were successively added to 3 mL molten top agar: 0.1 mL of a fresh bacterial culture (10exp9 cells/mL) of one of the tester strains, 0.1 ml of a dilution of the test item in DMSO and either 0.5 ml S9-mix (in case of activation assays) or 0.5 mL 0.1 M phosphate buffer (in case of non-activation assays). The ingredients were mixed on a Vortex and the content of the top agar tube was poured onto a selective agar plate. After solidification of the top agar, the plates were inverted and incubated in the dark at 37.0 ± 1.0°C for 48 ± 4 h. After this period revertant colonies (histidine independent (His+) for Salmonella typhimurium bacteria and tryptophan independent (Trp+) for Escherichia coli) were counted.
Second and third experiment: pre-incubation assay. The test item was tested both in the absence and presence of S9-mix in all tester strains. Top agar in top agar tubes was melted by heating to 45 ± 2°C. The following solutions were pre-incubated for 30 ± 2 minutes by 70 rpm at 37 ± 1°C, either 0.5 mL S9-mix (in case of activation assays) or 0.5 mL 0.1 M phosphate buffer (in case of non-activation assays), 0.1 mL of a fresh bacterial culture (10exp9 cells/mL) of one of the tester strains, 0.1 mL of a dilution of the test item in DMSO. After the pre-incubation period the solutions were added to 3 mL molten top agar. The ingredients were mixed on a Vortex and the content of the top agar tube was poured onto a selective agar plate. After solidification of the top agar, the plates were inverted and incubated in the dark at 37.0 ± 1.0°C for 48 ± 4 h. After this period revertant colonies (histidine independent (His+) for Salmonella typhimurium bacteria and tryptophan independent (Trp+) for Escherichia coli) were counted.
Colony counting. The revertant colonies were counted automatically with the Sorcerer Colony Counter. Plates with sufficient test item precipitate to interfere with automated colony counting were counted manually. Evidence of test item precipitate on the plates and the condition of the bacterial
background lawn were evaluated when considered necessary, macroscopically and/or microscopically by using a dissecting microscope. - Rationale for test conditions:
- Test conditions were as specified by the OECD guideline.
- Evaluation criteria:
- A Salmonella typhimurium reverse mutation assay and/or Escherichia coli reverse mutation assay is considered acceptable if it meets the following criteria:
a) The vehicle control and positive control plates from each tester strain (with or without S9-mix) must exhibit a characteristic number of revertant colonies when compared against relevant historical control data generated at Charles River Den Bosch.
b) The selected dose-range should include a clearly toxic concentration or should exhibit limited solubility as demonstrated by the preliminary toxicity range-finding test or should extend to 5 mg/plate.
c) No more than 5% of the plates are lost through contamination or some other unforeseen event. If the results are considered invalid due to contamination, the experiment will be repeated.
A test item is considered negative (not mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 or WP2uvrA is not greater than two (2) times the concurrent control, and the total number of revertants in tester strains TA1535, TA1537 or TA98 is not greater than three (3) times the concurrent control.
b) The negative response should be reproducible in at least one follow up experiment.
A test item is considered positive (mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 or WP2uvrA is greater than two (2) times the concurrent control, or the total number of revertants in tester strains TA1535, TA1537 or TA98 is greater than three (3) times the concurrent control.
b) In case a repeat experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one follow up experiment. - Statistics:
- Not required (mean values compared numerically).
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicity observed in the absence and presence of S9-mix at the highest dose level tested.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicity observed in the absence and presence of S9-mix at the highest dose level tested.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicity observed in the absence and presence of S9-mix at the highest dose level tested.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicity observed at dose levels of 1600 and 5000 µg/plate in the absence and presence of S9-mix
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Direct plate assay. 1,5-hexadiene was initially tested in the tester strains TA100 and WP2uvrA as a dose-range finding test with concentrations of 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 ¿g/plate in the absence and presence of S9-mix. Based on the results of the dose-range finding test, the following dose-range was selected for the mutation assay with the tester strains, TA1535, TA1537 and TA98 in the absence and presence of S9-mix: 17, 52, 164, 512, 1600 and
5000 ¿g/plate. Precipitation of 1,5-hexadiene on the plates was observed at the start of the incubation period at concentrations of 512 and 1600 ¿g/plate and upwards in the dose range finding and first experiment, respectively and at 5000 ¿g/plate at the end of the incubation period. To determine the toxicity of the test item, the reduction of the bacterial background lawn, the increase in the size of the microcolonies and the reduction of the revertant colonies were observed. Cytotoxicity, as evidenced by a reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains except for tester strain WP2uvrA where no toxicity was observed at any of the dose levels tested.
Pre-incubation assay. To obtain more information about the possible mutagenicity of the test item, a pre-incubation experiment was performed in the absence and presence of S9-mix. Based on the results of the first mutation assay, 1,5-hexadiene was tested up to the dose level of 5000 ¿g/plate in the tester strains TA1535, TA1537, TA98, TA100 and WP2uvrA. Precipitation of 1,5-hexadiene on the plates was not observed at the start of the incubation period. At the end of the incubation period, the test item precipitated on the plates at the top dose of 5000 ¿g/plate in tester strain TA100 in the absence and presence of S9-mix and in tester strains TA1535 and WP2uvrA in the presence of S9-mix. In tester strain TA1535 in the absence of S9-mix precipitation was observed at the dose levels of 1600 ¿g/plate and upwards. In all other tester strains no precipitation was observed. Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix. Due to the cytotoxicity in the second experiment, only three analyzable dose levels were left for the determination of the mutagenicity of the test item in the tester strain TA1535 in the presence of S9-mix and in tester strain TA1537 in the absence and presence of S9-mix. Therefore a third experiment was performed with concentrations of 1.7, 5.4 and 17 ¿g/plate to provide additional information. Precipitation of 1,5-hexadiene on the plates was not observed at the start and the end of the incubation period. No reduction of the bacterial background lawn and no biologically relevant decrease in the number of revertants were observed. - Remarks on result:
- other:
Any other information on results incl. tables
Dose-range finding test; direct plate assay. Mean = mean number of revertant colonies:
|
Without S9-mix |
|||
TA100 |
WP2uvrA |
|||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Positive control |
829 |
97 |
1325 |
78 |
Solvent control |
88 |
4 |
29 |
8 |
1.7 |
89 |
2 |
26 |
4 |
5.4 |
97 |
9 |
17 |
6 |
17 |
78 |
14 |
27 |
8 |
52 |
83 |
6 |
27 |
8 |
164 |
78 |
8 |
20 |
1 |
512 |
84 |
6 |
18 |
4 |
1600 |
68 |
18 |
14 |
6 |
5000 |
Reduced bacterial background |
16 |
3 |
|
|
WithS9-mix |
|||
TA100 |
WP2uvrA |
|||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Positive control |
1269 |
153 |
584 |
25 |
Solvent control |
87 |
13 |
33 |
13 |
1.7 |
95 |
3 |
27 |
1 |
5.4 |
92 |
5 |
34 |
12 |
17 |
101 |
9 |
28 |
2 |
52 |
99 |
13 |
30 |
1 |
164 |
87 |
13 |
23 |
7 |
512 |
88 |
14 |
25 |
5 |
1600 |
58 |
6 |
21 |
8 |
5000 |
Reduced bacterial background |
26 |
10 |
Experiment 1: mutagenic response in the Salmonella typhimurium reverse mutation assay. Direct plate assay. Mean = Mean number of revertant colonies.
|
Without S9-mix |
|||||
TA1535 |
TA1537 |
TA98 |
||||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Pos. ctrol. |
1056 |
38 |
1183 |
126 |
1103 |
95 |
Solvent |
11 |
4 |
6 |
4 |
12 |
4 |
17 |
14 |
2 |
5 |
1 |
15 |
8 |
52 |
9 |
3 |
8 |
5 |
11 |
6 |
164 |
12 |
1 |
7 |
2 |
15 |
5 |
512 |
12 |
5 |
6 |
5 |
11 |
4 |
1600 |
11 |
3 |
4 |
1 |
12 |
2 |
5000* |
11 |
5 |
4 |
2 |
9 |
1 |
|
WithS9-mix |
|||||
TA1535 |
TA1537 |
TA98 |
|
|||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Pos. ctrol. |
311 |
18 |
370 |
46 |
978 |
115 |
Solvent |
11 |
1 |
4 |
2 |
22 |
2 |
17 |
11 |
1 |
7 |
2 |
19 |
6 |
52 |
13 |
4 |
5 |
1 |
15 |
5 |
164 |
15 |
4 |
4 |
1 |
19 |
4 |
512 |
11 |
4 |
8 |
5 |
15 |
4 |
1600 |
13 |
7 |
6 |
4 |
12 |
2 |
5000* |
7 |
2 |
6 |
3 |
18 |
4 |
Slight precipitate and bacterial background lawn slightly reduced at 5000 µg/plate.
Experiment 2: mutagenic response in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay. Pre-incubation assay. Mean = Mean number of revertant colonies.
|
Without S9-mix |
|||||||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
||||||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Pos. ctrol. |
1205 |
59 |
196 |
19 |
1605 |
69 |
818 |
24 |
157 |
39 |
Solvent |
11 |
4 |
8 |
6 |
11 |
1 |
101 |
21 |
17 |
4 |
17 |
6 |
2 |
8 |
0 |
13 |
5 |
135 |
16 |
20 |
4 |
52 |
14 |
11 |
5 |
2 |
11 |
1 |
111 |
7 |
20 |
8 |
164 |
5 |
3 |
3 |
2 |
12 |
6 |
110 |
14 |
17 |
8 |
512 |
10* |
4 |
* |
- |
10 |
3 |
108 |
14 |
16 |
6 |
1600 |
* |
- |
* |
- |
* |
- |
83 |
- |
17 |
2 |
5000 |
* |
- |
* |
- |
* |
- |
* |
- |
20 |
4 |
|
WithS9-mix |
|||||||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
||||||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Pos. ctrol. |
283 |
28 |
276 |
20 |
833 |
83 |
1332 |
438 |
680 |
34 |
Solvent |
25 |
22 |
7 |
4 |
27 |
6 |
99 |
7 |
32 |
7 |
17 |
18 |
22 |
4 |
1 |
21 |
7 |
105 |
3 |
27 |
6 |
52 |
12 |
1 |
7 |
3 |
18 |
0 |
89 |
2 |
22 |
8 |
164 |
17 |
7 |
6 |
2 |
18 |
2 |
92 |
12 |
25 |
3 |
512 |
* |
- |
* |
- |
14 |
5 |
82 |
7 |
19 |
4 |
1600 |
* |
- |
* |
- |
* |
- |
* |
- |
19 |
6 |
5000 |
* |
- |
* |
- |
* |
- |
* |
- |
17 |
2 |
*Bacterial background extremely reduced.
Experiment 3: mutagenic response in the Salmonella typhimurium reverse mutation assay. Pre-incubation assay. Mean: mean number of revertant colonies.
|
Without S9-mix |
|||
TA1535 |
TA1537 |
|||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Positive control |
- |
- |
151 |
23 |
Solvent control |
- |
- |
10 |
4 |
1.7 |
- |
- |
10 |
2 |
5.4 |
- |
- |
9 |
1 |
17 |
- |
- |
7 |
2 |
|
WithS9-mix |
|||
TA100 |
WP2uvrA |
|||
Dose (µg/plate) |
Mean |
SD |
Mean |
SD |
Positive control |
247 |
3 |
221 |
6 |
Solvent control |
13 |
3 |
4 |
1 |
1.7 |
8 |
4 |
8 |
4 |
5.4 |
9 |
3 |
6 |
3 |
17 |
12 |
4 |
7 |
1 |
Applicant's summary and conclusion
- Conclusions:
- Based on the results of this study it is concluded that 1,5-hexadiene is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
- Executive summary:
The objective of this study was to determine the potential of 1,5-hexadiene and/or its metabolites to induce reverse mutations at the histidine locus in several strains of Salmonella typhimurium (S. typhimurium; TA98, TA100, TA1535, and TA1537), and at the tryptophan locus of Escherichia coli (E. coli) strain WP2uvrA in the presence or absence of an exogenous mammalian metabolic activation system (S9).
The test was performed in two independent experiments, at first a direct plate assay was performed and secondly and third a pre-incubation assay. An additional pre-incubation assay was performed in the absence and presence of S9-mix.
The study procedures described in this report were based on OECD 471 guideline.
Batch BSC-433-4-0488-5 of 1,5-hexadiene was a clear colourless liquid with a purity of 99.4%. The vehicle of the test item was dimethyl sulfoxide.
In the dose-range finding study, the test item was initially tested up to concentrations of 5000 ¿g/plate in the strains TA100 and WP2uvrA in the direct plate assay. 1,5-hexadiene precipitated on the plates at the top dose level of 5000 ¿g/plate. Cytotoxicity, as evidenced by a reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in tester strain TA100 at dose levels of 1600 and 5000 ¿g/plate in the absence and presence of S9-mix. In tester strain WP2uvrA, no toxicity was observed at any of the dose levels tested. Results of this dose-range finding test were reported as part of the first mutation assay.
In the first mutation experiment, the test item was tested up to concentrations of 5000 ¿g/plate in the strains TA1535, TA1537 and TA98. 1,5-hexadiene precipitated on the plates at this dose level. Cytotoxicity, as evidenced by a reduction of the bacterial background lawn, was observed in all tester strains in the absence and presence of S9-mix at the highest dose level tested.
In the second mutation experiment, the test item was tested up to concentrations of 5000 ¿g/plate in the tester strains TA1535, TA1537, TA98, TA100 and WP2uvrA in the pre-incubation assay. The test item precipitated on the plates at the top dose of 5000 ¿g/plate in tester strain TA100 in the absence and presence of S9-mix and in tester strains TA1535 and WP2uvrA in the presence of S9-mix. In tester strain TA1535 in the absence of S9-mix precipitation was observed at the dose levels of 1600 ¿g/plate and upwards. In all other tester strains no precipitation was observed. Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix.
Due to severe cytotoxicity in tester strain TA1535 in the absence of S9-mix and in tester strain TA1537 in the absence and presence of S9-mix in the pre-incubation assay, an additional experiment was performed. In the additional experiment the test item was tested up to concentrations of 17 ¿g/plate in tester strain TA1535 in the absence of S9-mix and in tester strain TA1537 in the absence and presence of S9-mix in the pre-incubation assay. The test item did not precipitate on the plates at this dose level. The bacterial background lawn was not reduced at any of the concentrations tested and no biologically relevant decrease in the number of revertants was observed.
The negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
The test item did not induce a significant dose-related increase in the number of revertant (His+) colonies in each of the four tester strains (TA1535, TA1537, TA98 and TA100) and in the number of revertant (Trp+) colonies in tester strain WP2uvrA both in the absence and presence of S9-metabolic activation. These results were confirmed in a follow-up experiment.
In conclusion, based on the results of this study it is concluded that 1,5-hexadiene is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.